[LGND] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 745.21%
YoY- 15,459.77%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 19,521 29,648 21,192 17,701 18,418 14,602 22,998 -10.36%
PBT -9,644 9,571 5,826 7,284 22,292 -74 7,012 -
Tax -3,881 3,694 -515 -217,255 265 15 279 -
NP -5,763 6,608 6,341 199,165 23,564 754 7,055 -
Tax Rate - -38.60% 8.84% 2,982.63% -1.19% - -3.98% -
Total Cost 25,284 23,040 14,851 -181,464 -5,146 13,848 15,943 36.03%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -29.52 22.29 29.92 1,125.16 127.94 5.16 30.68 -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -0.28 0.32 0.32 10.01 1.19 0.04 0.35 -
EPS Diluted -0.28 0.30 0.29 9.28 1.11 0.04 0.34 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.